Participants Announced for Business Programme of Drug Security Forum

The list of participants in the business programme of the ‘Ensuring Drug Security’ Russian Pharmaceutical Forum has been published on the event’s official website. The Forum will take place on 5 June 2024, the opening day of the St. Petersburg International Economic Forum. The event is being organized by the Roscongress Foundation with the support of the Russian Ministry of Health and the Russian State Duma’s Committee on Health Protection.

“The Drug Security Forum is an annual event that brings together leading experts in the pharmaceutical industry on a single platform. The goal of the Forum is to discuss current issues concerning the development of the industry, as well as to support leading domestic drug manufacturers. The Forum’s business programme covers a wide range of topics that are crucial to ensuring the country’s medicinal sovereignty and improving the quality of medical care. The ‘Pharma 2030’ strategy and long-term planning policy, new approaches to the circulation of drugs, the future of the diagnosis and treatment of autoimmune diseases, innovative pharmaceuticals, genetics, and much more will be discussed. This year, special attention will be paid to drug security in the BRICS space,” Adviser to the Russian President Anton Kobyakov said.

The event will be attended by Russian Minister of Health Mikhail Murashko; Yamal-Nenets Autonomous Area Governor Dmitry Artyukhov; Russian Deputy Minister of Industry and Trade Yekaterina Priyezzheva; VEB.RF First Deputy Chairman Alexander Braverman; Director of the Russian Federal Service for Surveillance in Healthcare Alla Samoilova; Oncologist Surgeon and Chairman of the Russian State Duma’s Committee on Health Protection Badma Bashankaev; First Deputy Chairperson of the Federation Council’s Committee on Federal Structure, Regional Policy, Local Government, and Northern Affairs Galina Karelova; Director of the National Medical Research Centre for Endocrinology of the Russian Ministry of Health Natalya Mokrysheva; Director of the National Medical Research Centre for Therapy and Preventive Medicine of the Russian Ministry of Health and Chief Visiting Specialist for Therapy and General Medical Practice of the Russian Ministry of Health Oksana Drapkina; General Director of the Almazov National Medical Research Centre of the Russian Ministry of Health Yevgeny Shlyakhto; General Director of the Centre for Healthcare Quality Assessment and Control of the Russian Ministry of Health Vitaly Omelyanovsky; Chairman of the Management Board of the Association of Pharmaceutical Manufacturers of the Eurasian Economic Union Alexey Kedrin; President of the Russian Haemophilia Society and Co-Chairman of the Russian Patients Association Yury Zhulev; Econix Research, Analysis and Consulting Inc CEO Guvenc Kockaya; Executive Director of the BRICS Chamber of Commerce and Industry Prann Sharma; Skopinpharm CEO Inga Nizharadze; EFKO Group Executive Director and Member of the Board of Directors Sergey Ivanov; Nizhpharm Group CEO Oksana Pozdnyakova; GEROPHARM CEO Pyotr Rodionov; Akrikhin President Denis Chetverikov; Velpharm Group President Lyudmila Shcherbakova; AstraZeneca Russia and Eurasia CEO Irina Panarina, PSK Pharma CEO Yevgenia Shapiro; and others.

In accordance with Russia’s BRICS chairship, much of the event’s business programme will be devoted to issues related to long-term fruitful cooperation between BRICS countries in healthcare and the development of high technologies and the pharmaceutical industry.

The plenary session of the Forum is ‘Drug Security in the BRICS Space’.